£0.68
2.43%
London, Oct 01, 01:10 pm BST. Market open.
ISIN
GB00BL6NGV24
Symbol
DOCS

Dr Martens Target price 2026 - Analyst rating & recommendation

Dr Martens Classifications & Recommendation

Buy
60%
Hold
40%

Dr Martens Price Target

Target Price £0.87
Price £0.70
Potential
Number of Estimates 5
5 Analysts have issued a price target Dr Martens 2027 . The average Dr Martens target price is £0.87. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 6 Analysts recommend Dr Martens to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Dr Martens stock has an average upside potential 2027 of . Most analysts recommend the Dr Martens stock at Purchase.

Sales and Margin forecast 2027, 2028 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Mar '26 2027
Estimates
Revenue Million £ 764.90 789.30
2.88% 3.19%
EBITDA Margin 19.31% 20.60%
6.80% 6.68%
Net Margin 3.11% 6.11%
444.58% 96.37%

7 Analysts have issued a sales forecast Dr Martens 2027 . The average Dr Martens sales estimate is

£789m
unlock
. This is
3.19% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
£832m 8.79%
unlock
, the lowest is
£748m 2.18%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 £765m 2.88%
2027
£789m 3.19%
unlock
2028
£827m 4.75%
unlock
2029
£867m 4.87%
unlock
2030
£920m 6.05%
unlock
2031
£978m 6.32%
unlock
2032
£1.0b 4.64%
unlock
2033
£1.1b 4.69%
unlock

7 Analysts have issued an Dr Martens EBITDA forecast 2027. The average Dr Martens EBITDA estimate is

£163m
unlock
. This is
10.11% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
£174m 17.94%
unlock
, the lowest is
£153m 3.44%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 £148m 3.72%
2027
£163m 10.11%
unlock
2028
£179m 9.89%
unlock
2029
£193m 8.20%
unlock
2030
£203m 4.97%
unlock

EBITDA Margin

2026 19.31% 6.80%
2027
20.60% 6.68%
unlock
2028
21.62% 4.95%
unlock
2029
22.30% 3.15%
unlock
2030
22.08% 0.99%
unlock

7 Dr Martens Analysts have issued a net profit forecast 2027. The average Dr Martens net profit estimate is

£48.2m
unlock
. This is
102.65% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
£54.2m 127.90%
unlock
, the lowest is
£43.1m 81.18%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 £23.8m 428.89%
2027
£48.2m 102.65%
unlock
2028
£58.7m 21.79%
unlock
2029
£67.7m 15.30%
unlock

Net Margin

2026 3.11% 444.58%
2027
6.11% 96.37%
unlock
2028
7.11% 16.37%
unlock
2029
7.81% 9.85%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Mar '26 2027
Estimates
Earnings Per Share £ 0.02 0.05
150.00%
P/E 13.90
EV/Sales 1.11

7 Analysts have issued a Dr Martens forecast for earnings per share. The average Dr Martens EPS is

£0.05
unlock
. This is
66.67% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
£0.06 100.00%
unlock
, the lowest is
£0.05 66.67%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 £0.02
2027
£0.05 150.00%
unlock
2028
£0.06 20.00%
unlock
2029
£0.07 16.67%
unlock

P/E ratio

Current
2027
13.90 40.51%
unlock
2028
11.42 17.84%
unlock
2029
9.90 13.31%
unlock

Based on analysts' sales estimates for 2027, the Dr Martens stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.14 20.28%
2027
1.11 2.93%
unlock
2028
1.06 4.53%
unlock
2029
1.01 4.65%
unlock
2030
0.95 5.71%
unlock
2031
0.89 5.94%
unlock
2032
0.85 4.44%
unlock
2033
0.82 4.49%
unlock

P/S ratio

Current 0.87 22.83%
2027
0.84 3.08%
unlock
2028
0.80 4.54%
unlock
2029
0.76 4.64%
unlock
2030
0.72 5.71%
unlock
2031
0.68 5.94%
unlock
2032
0.65 4.43%
unlock
2033
0.62 4.49%
unlock

Current Dr Martens Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
RBC Capital Markets
Locked
➜
Locked
Locked Jun 02 2026
Berenberg Bank
Locked
➜
Locked
Locked May 19 2026
Berenberg Bank
Locked
➜
Locked
Locked May 06 2026
RBC Capital Markets
Locked
➜
Locked
Locked Feb 03 2026
Berenberg Bank
Locked
➜
Locked
Locked Jan 27 2026
Berenberg Bank
Locked
➜
Locked
Locked Nov 27 2025
Peel Hunt Limited
Locked
➜
Locked
Locked Nov 20 2025
Analyst Rating Date
Locked
RBC Capital Markets:
Locked
➜
Locked
Jun 02 2026
Locked
Berenberg Bank:
Locked
➜
Locked
May 19 2026
Locked
Berenberg Bank:
Locked
➜
Locked
May 06 2026
Locked
RBC Capital Markets:
Locked
➜
Locked
Feb 03 2026
Locked
Berenberg Bank:
Locked
➜
Locked
Jan 27 2026
Locked
Berenberg Bank:
Locked
➜
Locked
Nov 27 2025
Locked
Peel Hunt Limited:
Locked
➜
Locked
Nov 20 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today